Home

DiaMedBase 

Diabetes Medicinal Plant Database

Browse    A B C D E F G H I J K L M N O P Q R S T U V W X Y Z     Plants List
Caesalpinia
Cajanus
Calamintha
Camellia
Capparis
Capsicum
Caralluma
Carissa
Carum
Casearia
Cassia
Castanospermum
Catharanthus
Cecropia
Centaurea
Centaurium
Cephalandra
Chamaemelum
Chelidonium
Chrysanthemum
Chrysobalanus
Cicer
Cichorium
Cimicifuga
Cinnamomum
Cirsium
Cissus
Citrullus
Citrus
Clausena
Cleome
Cnidium
Cnidoscolus
Coccinia
Cogniauxia
Colocassia
Commelina
Commiphora
Convallaria
Convolvulus
Coptis
Coriandrum
Corni
Cornus
Coscinium
Costus
Cressa
Crotalaria
Croton
Cryptolepis
Cucumis
Cucurbita
Cuminum
Curcuma
Cyamopsis
Cyclocarya
Cymbopogon
 
DiaMedBase ID   DMPCc205
Medicinal Plant   Galega officinalis, Cressa cretica, Mangifera indica and Syzygium jambolanum
Plant part(s)   Whole plant
Objective   To treat diabetes mellitus through the ethanolic extract of a powdered mixture of equal proportions of G. officinalis, Cressa cretica, Mangifera indica and Syzygium jambolanum
Journal Source   J Pharm Pharmacol, 1999; 51(11):1313-1319
Title   Novel weight-reducing activity of Galega officinalis in mice
Authors   Palit P, Furman BL, Gray AI
Address   Phytochemistry Research Laboratories, Department of Pharmaceutical Sciences, University of Strathclyde, Glasgow, UK
Abstract  

Galega officinalis (galega, Goat's Rue, French Lilac) is well known for its hypoglycaemic action and has been used as part of a plant mixture in the treatment of diabetes mellitus. During pharmacological investigations of an ethanolic extract of a powdered mixture of equal proportions of G. officinalis, Cressa cretica, Mangifera indica and Syzygium jambolanum, a weight reducing effect of galega was discovered. In this study we have investigated the novel weight reducing effect of galega in mice. Galega herb (10% w/w in the diet) caused a significant reduction in body weight in both normal and genetically obese (ob/ob) animals treated for 28 days when compared with respective controls (P < 0.01). In normal mice, the weight loss was reversible and initially associated with a transient reduction in food intake but was then maintained even in the presence of increased eating above the control level. Pair-fed normal mice receiving galega for seven days also showed significant weight loss (P < 0.01, compared with the control) in the presence of increasing food intake. In sharp contrast, weight loss in galega-treated ob/ob mice was accompanied by a persistent reduction in food intake over the 28-day treatment period. Post-mortem examinations of all galega-treated mice revealed a striking absence of body fat. Serum glucose was significantly reduced in both strains of mice receiving galega for 28 days (P < 0.01), whereas serum insulin was significantly reduced only in obese mice (P < 0.01). In summary, together with its established hypoglycaemic effects, galega has a novel weight reducing action that, in normal mice, is largely independent of a reduction in food intake. The mechanism of the weight reducing action of galega is unclear but involves loss of body fat.

Diseases   Disease Link

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

          Copyright © 2006 ProGene Biosciences
            Last modified: March, 2006
             info@progenebio.in